A.M. Edition for Sept. 26. President Trump unveils new levies on branded or patented drugs from pharmaceutical companies that aren't building manufacturing plants in America. Plus, a federal grand jury in Virginia indicted former FBI director James Comey on charges of making false statements and obstruction during the bureau’s earlier investigation of the Trump campaign’s ties to Russia in the 2016 election. And, WSJ foreign correspondent Sune Rasmussen details the difficulty in defending against drone incursions for NATO, an alliance built for more traditional military conflicts, in a new age of so-called hybrid attacks. Caitlin McCabe hosts. Sign up for the WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from WSJ What’s News
Transcribed and ready to explore now
The Trump Administration Is Quietly Watering Down Some Tariffs
17 Oct 2025
WSJ What’s News
What’s News in Markets: Tesla Turmoil, Steelmaker Rallies, Dollar General Gains
07 Jun 2025
WSJ What’s News
Trump Bars U.S. Travel for Citizens of 12 Countries
05 Jun 2025
WSJ What’s News
Why Americans Are Turning to Discount Stores
04 Jun 2025
WSJ What’s News
U.S. Doubles Steel, Aluminum Tariffs to 50%
04 Jun 2025
WSJ What’s News
Why Wall Street Is Raising the Alarm Over U.S. Debt
03 Jun 2025
WSJ What’s News